Thrombolysis is the first effective treatment for stroke. Considerable prec
linical and early clinical studies set the stage for the final, definitive
demonstration of rtPA efficacy. Since the publication of the original trial
, there have been a number of subsequent analyses of subgroups. In particul
ar, the authors discuss the use of thrombolytic therapy in elderly people.
There is limited evidence that rtPA is effective at all ages. Criteria for
selecting patients and management guidelines are presented.